Dr. Kiran Kharsodiya | Immunology | Mody University of Science and Technology | India
Kiran Kharsodiya is a dedicated Research Scientist and Microbiologist with over eight years of experience in clinical, pharmaceutical, and microbiological research. Currently serving as Project Research Scientist II under the ICMR-CAR-MEDTECH Project at St. John’s Research Institute, Bengaluru, Kiran has made impactful contributions in designing and executing large-scale intervention and medical device trials. His expertise lies in microbiological examination, molecular analysis, and the study of host-inflammatory pathways. Kiran holds a strong research background supported by multiple peer-reviewed publications in international journals, reflecting his commitment to advancing medical science. His doctoral research at Mody University focuses on microbiological and molecular analysis of abnormal vaginal discharge and its pathophysiological effects, bridging microbiology and women’s health. A recipient of CSIR-NET qualification in 2024, Kiran exemplifies innovation, critical thinking, and leadership in translational research. His collaborative approach and scientific rigor continue to shape impactful research outcomes with real-world clinical applications.
Author Profiles
Orcid | Google Scholar
Education
Kiran Kharsodiya has pursued a strong academic foundation in microbiology and life sciences, which has shaped his career in biomedical research. He is currently completing his Doctor of Philosophy (PhD) at Mody University, India, where his thesis focuses on “Microbiological Examination and Molecular Analysis in Abnormal Vaginal Discharge and Comparative Analysis of its Pathophysiological Effect.” His PhD integrates molecular biology with clinical microbiology to explore diagnostic and therapeutic strategies in women’s health. Kiran earned his Master of Science (Microbiology) degree from Devi Ahilya University, Indore, India, where he specialized in advanced microbiological techniques and clinical research applications. He also completed a Bachelor of Science (Industrial Microbiology) from the same university, where his academic excellence and research curiosity laid the foundation for his career. Complementing his education, he successfully qualified the prestigious CSIR-NET exam in 2024, showcasing his academic excellence and research potential.
Experience
Currently working as Project Research Scientist II at St. John’s Research Institute, Bengaluru, under the ICMR-CAR-MEDTECH Project (2024–present), Kiran Kharsodiya brings extensive expertise in microbiology and clinical trial management. His role involves designing and executing large-scale pharmaceutical, medical device, and clinical trials, with a focus on ensuring regulatory compliance and high-quality data collection. He actively contributes to Phase III trials, large intervention efficiency studies, and the development of non-medical trial protocols. His ability to coordinate daily operations, collaborate with multidisciplinary teams, and analyze clinical trial data demonstrates his strong leadership in research environments. Kiran is also skilled in publishing and disseminating research findings through scientific journals and conferences, reinforcing his contributions to the broader scientific community. With more than eight years of research experience, he has developed a reputation for innovation, scientific precision, and problem-solving, contributing significantly to advancing biomedical and microbiological research in India and beyond.
Awards and Honors
Throughout his career, Kiran Kharsodiya has consistently demonstrated academic excellence and research dedication, earning several notable distinctions. His most recent achievement includes qualifying the prestigious CSIR-NET examination in 2024, a highly competitive recognition that reflects his advanced scientific knowledge and potential for research leadership. His contributions to translational microbiological and clinical research have also been acknowledged through multiple peer-reviewed publications, a testament to his innovation and dedication. Kiran has been invited to present his findings at national and international scientific conferences, highlighting the global relevance of his work. His collaborative research within multi-institutional projects, such as the ECGRI study on endometriosis and ovarian cancer, further underscores his recognition within the scientific community. These milestones, combined with his proven ability to integrate microbiology, molecular biology, and clinical research, establish him as a promising scientist whose work continues to be recognized for both academic rigor and societal impact.
Research Focus
Kiran Kharsodiya’s research focus lies at the intersection of microbiology, immunology, and women’s health. His PhD work emphasizes microbiological examination and molecular analysis of abnormal vaginal discharge, aiming to identify pathogenic flora, host-inflammatory responses, and their pathophysiological effects. This contributes to better diagnostic and therapeutic strategies for gynecological conditions. His studies also expand into the role of biomarkers, such as cytokines and microRNAs, in diseases like endometriosis and ovarian cancer, highlighting his interest in translational research. By integrating clinical microbiology, immunological pathways, and molecular diagnostics, Kiran seeks to improve early detection and intervention in reproductive health disorders. His work extends to exploring host-pathogen interactions, inflammation markers such as IL-6, IL-1β, TNF-α, and their predictive value in microbial infections. This research bridges fundamental microbiology with clinical applications, addressing pressing healthcare challenges. His long-term goal is to advance diagnostic tools and contribute meaningfully to global women’s healthcare solutions.
Publications
-
Protocol for a case–control study investigating the clinical phenotypes and genetic regulation of endometriosis in Indian women: the ECGRI study.
-
The relationship between melatonin 1-2 receptor expression in patients with epithelial ovarian cancer and survival.
-
Endometriosis in India: Analysing diagnostic delays, geographic variations, clinical phenotypes and associated characteristics from the ECGRI Study.
-
Predictive value of IL-6, IL-1β, TNF-α, and vaginal pH in diagnosing vaginal microbial infections: A host-inflammatory axis perspective.
-
Identification and characterization of pathogenic microbial flora associated with abnormal vaginal discharge: A microbiological examination study.
-
A pilot study of circulating microRNA-125b as a diagnostic & prognostic biomarker for epithelial ovarian cancer.
-
2022-RA-195-ESGO miRNA-125b expression in epithelial ovarian cancer.
Conclusion
Kiran Kharsodiya is a dynamic researcher with strong expertise in microbiology, immunology, and clinical research, making significant contributions to women’s health and translational medicine. His blend of academic rigor, practical experience in large-scale trials, and impactful publications positions him as a promising leader in biomedical sciences. With a clear focus on innovation, collaboration, and clinical relevance, he continues to advance knowledge at the crossroads of microbiology and immunology, striving to improve diagnostic and therapeutic outcomes for global healthcare.